Author Archives: Rafi Farber

3 Canadian Cannabis ADRs to Consider as the Sector Takes Off

Cannabis stocks are making a comeback, no thanks to US-based medical marijuana companies. The United States Marijuana Index, a collection of 17 firms, is still languishing at 55% below its ...
Read Full Story »

3 Companies Spearheading the Antibiotics Space in 2018

This may turn out to be a pivotal year in antibiotic development, after decades of dramatic decline in the space. While 1980 to 1984 saw 18 new antibiotic approvals, the ...
Read Full Story »

McAfee One Year Later, Now a Bitcoin Pioneer

Last year, cybersecurity legend John McAfee came out of hiding and made a play to reinvigorate his name and brand by heading MGT Capital Investments and rebranding it as a ...
Read Full Story »

Why a California Ban on Internal Combustion Is Irrelevant

Following China’s proposed ban of the internal combustion engine by 2030, Governor Jerry Brown of California appears to have gotten a little jealous. He is now reportedly interested in eventually ...
Read Full Story »

Winners and Losers If Trump Carries Out Threat to Cut Off Trade With China

President Donald Trump apparently did not get Teddy Roosevelt’s memo about speaking softly and carrying a big stick. Of all the threats that he has made since his tenure as ...
Read Full Story »

Trump’s Trade War With China Disregards Companies Involved

A trade war is brewing between the United States and China, but the offended parties — U.S. companies operating in China supposed forced to hand over technology for access to ...
Read Full Story »

Why Time Warner May Jettison CNN Before Any AT&T Merger

CNN’s thinly veiled threat against an as-of-yet private citizen for criticizing the network in an internet meme is one of the more bizarre and arguably puerile moves a large media ...
Read Full Story »

Why the Fed May Not Be Able to Shrink Its Balance Sheet

Along with the Federal Reserve’s expected hike of the federal funds rate to a range of 1.00% to 1.25%, what really captured investor attention was the addendum the Federal Open ...
Read Full Story »

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag. But the truth is, Big ...
Read Full Story »

Why the Summer Looks Safe for Stocks This Year

Popular Wall Street sayings aren’t initiated in a vacuum. “Sell in May and go away” echoes are bouncing off the walls this time of year, and it is worth a ...
Read Full Story »

Fresh Off IPO, Therapix Biosciences Already Aiming at Tourette’s Phase 3 Trial

The road to a pivotal Phase 3 trial usually takes years following an initial public offering, but Therapix Biosciences Ltd. (NASDAQ: TRPX) may reach that stage in just a few ...
Read Full Story »

5 Trump Victory Stocks May Be Getting Overbought

The question of whether stock prices are driven by current events or whether these events only serve as bumps on a road that equities are already taking will be debated ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
Dodge Challenger

Could Fiat Chrysler Become the Valeant of the Auto Industry?

Reports are now emerging that Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is being investigated by both the U.S. Securities and Exchange Commission (SEC) and the U.S. Department of Justice. The former ...
Read Full Story »
Money close-up

3 Dow Stocks to Own as the Dollar Supply Breaks Record High

Any possible summer downturn for stocks just got that much more unlikely. The latest Federal Reserve Money Stock Measures report puts the amount of money circulating in the U.S. economy ...
Read Full Story »